Endoscopic Sleeve Gastroplasty Is Cost Saving Versus Semaglutide

FRIDAY, April 12, 2024 -- For individuals with class II obesity, endoscopic sleeve gastroplasty (ESG) is cost saving compared with semaglutide, according to a study published online April 12 in JAMA Network Open.Muhammad Haseeb, M.D., from Brigham...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news